Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Afinitor 10mg


Contraindicated
Reproductive toxicity in animals

Contraindicated
Afinitor 10mg :
Type Medicine Authorised
Originator B
Agent Khalil Fattal & Fils
Distributor Khalil Fattal & Fils
Laboratory Novartis
Responsible Party Novartis Pharma AG
Origin Switzerland
Manufacturer Novartis Pharma Stein AG
Origin Switzerland
ATC L01XE10
Revision Date 01/01/2013

Your comment will appear shortly after approval

Afinitor 10mg :

Revision Date : 16/12/2014


Effect Frequency
Abdominal pain Common
Acne Common
Acute respiratory distress syndrome Rare
Ageusia (Taste loss) Uncommon
Alopecia Common
ALT increased Common
Alveolitis Rare
Amenorrhoea secondary Uncommon
Anaemia Very Common
Angioedema (Angioneurotic oedema) (Quincke oedema) Rare
Aphthous stomatitis Common
Aplasia pure red cell (PRCA) Rare
Arthralgia (Pain joint) (Joint ache) Common
Aspergillosis Not known
AST increased Common
Asthenia Very Common
Blood creatinine increased Common
Candidiasis (Candida infection) Not known
Congestive heart failure Uncommon
Conjunctivitis Uncommon
Cough Common
Decreased appetite Very Common
Deep vein thrombosis Uncommon
Dehydration Common
Diabetes mellitus Common
Diarrhoea (Diarrhea) Very Common
Dry mouth (Xerostomia) Common
Dry skin Common
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance) Very Common
Dyspepsia Common
Dysphagia Common
Dyspnoea (dyspnea) Common
Epistaxis (Nasal bleeding) Very Common
Erythema Common
Eyelid oedema Common
Fatigue Very Common
Flushing Uncommon
Glossitis Uncommon
Glossodynia Uncommon
Haemoptysis Uncommon
Haemorrhage Common
Hand and foot syndrome (Palmar-plantar erythrodysaesthesia syndrome) Common
Headache Very Common
Hepatitis B reactivation Not known
Herpes zoster Uncommon
Hypercholesterolaemia Very Common
Hyperglycaemia Very Common
Hyperlipidaemia Common
Hypersensitivity Uncommon
Hypertension Common
Hypertriglyceridaemia Common
Hypocalcaemia Common
Hypokalaemia Common
Hypophosphataemia Common
Infection Very Common
Insomnia Common
Interstitial pneumonitis Common
Leucopenia (Leukopenia) Common
Lung infiltration (pulmonary infiltration) Common
Lymphopenia Common
Menstruation irregular Common
Mouth ulceration Common
Mucosal inflammation Common
Nail disorders Common
Nausea Very Common
Neutropenia Common
Non-cardiac chest pain Uncommon
Oedema peripheral Very Common
Onychoclasis Common
Opportunistic infections Not known
Oral pain Common
Pancytopenia Uncommon
Pneumocystis carinii pneumonia Not known
Pneumonia Common
Pneumonitis Very Common
Proteinuria Common
Pruritus Very Common
Pulmonary alveolar haemorrhage Rare
Pulmonary embolism Uncommon
Pulmonary toxicity Rare
Pyrexia Common
Renal failure Common
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute) Uncommon
Sepsis (Systemic infection) (Sepsis state) Uncommon
Skin exfoliation (Flaking skin) Common
Skin lesion Common
Skin rash Very Common
Stomatitis Very Common
Thrombocytopenia (Thrombopenia) Common
Tongue ulceration Common
Urine output increased Uncommon
Vomiting Common
Weight decreased (Weight loss) Very Common
Wound healing delayed Rare

Different Units By MoH Code

Revision Date : 07/12/2021

Revision Date : 07/12/2021

Afinitor 10mg  MoH 6930 :
Form Tablet
Packaging Plaquettes (Al/Polyamide/Al/PVC)
Package Size Box of 30
Strength 10mg
Storage Condition <30°C protect from humidity & light
Public Price 3247029 L.L.
Stratum E2
NSSF ✔
Quarantine ✘
Reg. Number 96704/12
Submission date 01/01/2013
Registration Year 2013


Price Comparison

● Country: Italy
● Package Size: 30
● Public Price: 5719.63 EUR ( 105,127,085.38 LBP )
● Pack size unit used: 30
● Cost/Unit: 190,6543 EUR ( 3,492,209.50 LBP )
● Exfactory Price: 3465.6 EUR
● Pricing Date: 17/12/2019
● Type: Medicine Authorised

● Country: Qatar
● Package Size: 30
● Public Price: 21778 QAR ( 90,390,895.68 LBP )
● Pack size unit used: 30
● Cost/Unit: 725,9333 QAR ( 3,009,156.00 LBP )
● Pharmacy Price: 17888.73168394 QAR ( 74248254.178094 LBP )
● Pricing Date: 28/01/2021
● Type: Medicine Authorised

● Country: Oman
● Package Size: 30
● Public Price: 2292.96 OMR ( 90,114,474.48 LBP )
● Pack size unit used: 30
● Cost/Unit: 76,432 OMR ( 2,986,838.00 LBP )
● Pricing Date: 19/02/2021
● Type: Medicine Authorised

● Country: Abu Dhabi
● Package Size: 30
● Public Price: 20350 AED ( 83,658,036.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Pharmacy Price: 17335.3 AED ( 71264724.888 LBP )
● Pricing Date: 27/01/2021
● Type: Medicine Authorised

● Country: UAE
● Package Size: 30's (10's Blister x 3)
● Public Price: 20350 AED ( 83,658,036.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Pharmacy Price: 17335.32 AED ( 71264807.1072 LBP )
● Pricing Date: 21/08/2019
● Type: Medicine Authorised

● Country: Bahrain
● Package Size: 30
● Public Price: 1935.62 BHD ( 77,658,564.83 LBP )
● Pack size unit used: 30
● Cost/Unit: 64,5207 BHD ( 2,567,729.28 LBP )
● Reference: nhra
● Pricing Date: 09/02/2021
● Type: Medicine Authorised

● Country: Jordan
● Package Size: 30
● Public Price: 3525.52 JOD ( 75,235,266.65 LBP )
● Pack size unit used: 30
● Cost/Unit: 117,5173 JOD ( 2,496,802.23 LBP )
● Reference: JFDA
● Pricing Date: 02/01/2021
● Type: Medicine Authorised

● Country: Germany
● Package Size: 30
● Public Price: 3990.6 EUR ( 73,347,427.53 LBP )
● Pack size unit used: 30
● Cost/Unit: 133,02 EUR ( 2,444,546.65 LBP )
● Pricing Date: 24/10/2020
● Type: Medicine Authorised

● Country: The Netherlands
● Package Size: 30
● Public Price: 3883.75 EUR ( 71,383,519.19 LBP )
● Pack size unit used: 30
● Cost/Unit: 129,4583 EUR ( 2,371,026.45 LBP )
● Pharmacy Price: 3876.75 EUR ( 71254858.8375 LBP )
● Reference: Zorginstituut Nederland
● Pricing Date: 15/06/2019
● Type: Medicine Authorised

● Country: Denmark
● Package Size: 30
● Public Price: 28871.9 DKK ( 71,052,879.74 LBP )
● Pack size unit used: 30
● Cost/Unit: 962,3967 DKK ( 2,367,453.14 LBP )
● Pharmacy Price: 21461.02 DKK ( 52814926.3894 LBP )
● Reference: Danish Medicine Agency
● Pricing Date: 19/05/2021
● Type: Medicine Authorised

● Country: Finland
● Package Size: 30
● Public Price: 3659.05 EUR ( 67,253,521.95 LBP )
● Pack size unit used: 30
● Cost/Unit: 121,9683 EUR ( 2,223,986.05 LBP )
● Reference: Kela
● Pricing Date: 22/04/2021
● Type: Medicine Authorised

● Country: Iceland
● Package Size: 30
● Public Price: 580788 ISK ( 64,386,157.68 LBP )
● Pack size unit used: 30
● Cost/Unit: 19359,6 ISK ( 2,146,138.74 LBP )
● Pharmacy Price: 461869 ISK ( 51202797.34 LBP )
● Reference: Icelandic Medicines Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Spain
● Package Size: 30
● Public Price: 3491.16 EUR ( 64,167,695.36 LBP )
● Pack size unit used: 30
● Cost/Unit: 116,372 EUR ( 2,132,085.80 LBP )
● Reference: Agencia Española de Medicamentos y Productos Sanitarios
● Pricing Date: 06/05/2021
● Type: Medicine Authorised

● Country: Sweden
● Package Size: 30
● Public Price: 35281.43 SEK ( 63,510,454.96 LBP )
● Pack size unit used: 30
● Cost/Unit: 1176,0477 SEK ( 2,116,929.36 LBP )
● Pharmacy Price: 34533.02 SEK ( 62163234.6322 LBP )
● Pricing Date: 23/04/2020
● Type: Medicine Authorised

● Country: Norway
● Package Size: 30
● Public Price: 35850.2 NOK ( 62,030,525.55 LBP )
● Pack size unit used: 30
● Cost/Unit: 1195,0067 NOK ( 2,067,672.65 LBP )
● Pharmacy Price: 28089.36 NOK ( 48602176.9272 LBP )
● Reference: Norwegian Medicine Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

● Country: Ireland
● Package Size: 30
● Public Price: 3265.76 EUR ( 60,024,832.09 LBP )
● Pack size unit used: 30
● Cost/Unit: 108,8587 EUR ( 1,985,045.40 LBP )
● Pricing Date: 08/10/2020
● Type: Medicine Authorised

● Country: Cyprus
● Package Size: 30 TABS
● Public Price: 3063.45 EUR ( 56,306,364.17 LBP )
● Pack size unit used: 30
● Cost/Unit: 102,115 EUR ( 1,874,765.10 LBP )
● Reference: Cyprus Minister of Health
● Pricing Date: 24/03/2021
● Type: Medicine Authorised

● Country: UK
● Package Size: 30
● Public Price: 2673 GBP ( 53,863,008.21 LBP )
● Pack size unit used: 30
● Cost/Unit: 89,1 GBP ( 1,793,418.53 LBP )
● Reference: DMD
● Pricing Date: 08/03/2021
● Type: Medicine Authorised

● Country: Czech Republic
● Package Size: 30
● Public Price: 71550.46 CZK ( 49,424,195.75 LBP )
● Pack size unit used: 30
● Cost/Unit: 2385,0153 CZK ( 1,647,462.60 LBP )
● Reference: SUKL
● Pricing Date: 28/02/2020
● Type: Medicine Authorised

● Country: Greece
● Package Size: 30
● Public Price: 2692.78 EUR ( 49,493,431.04 LBP )
● Pack size unit used: 30
● Cost/Unit: 89,7593 EUR ( 1,635,824.45 LBP )
● Exfactory Price: 2435.83 EUR
● Pharmacy Price: 2472.37 EUR ( 45442284.2185 LBP )
● Reference: National Organization for Medicines
● Pricing Date: 25/02/2021
● Type: Medicine Authorised

● Country: France
● Package Size: 30
● Public Price: 2404.09 EUR ( 44,187,294.40 LBP )
● Pack size unit used: 30
● Cost/Unit: 80,1363 EUR ( 1,470,404.00 LBP )
● Reference: ansm
● Pricing Date: 15/05/2021
● Type: Medicine Authorised

● Country: Switzerland
● Package Size: 30
● Public Price: 2499.25 CHF ( 42,637,829.81 LBP )
● Pack size unit used: 30
● Cost/Unit: 83,3083 CHF ( 1,416,000.75 LBP )
● Exfactory Price: 2222.71 CHF
● Pricing Date: 04/04/2021
● Type: Medicine Authorised

● Country: Belgium
● Package Size: 30
● Public Price: 2256 EUR ( 41,465,392.80 LBP )
● Pack size unit used: 30
● Cost/Unit: 75,2 EUR ( 1,378,503.75 LBP )
● Reference: cbip
● Pricing Date: 02/12/2020
● Type: Medicine Authorised

● Country: Turkey
● Package Size: 30
● Public Price: 9940.89 TRY ( 19,093,368.01 LBP )
● Pack size unit used: 30
● Cost/Unit: 331,363 TRY ( 635,748.39 LBP )
● Pricing Date: 28/10/2020
● Type: Medicine Authorised

● Country: Egypt
● Package Size: Boîte de 30
● Public Price: 19100 EGP ( 18,337,910.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 636,6667 EGP ( 610,623.60 LBP )
● Pricing Date: 02/12/2019
● Type: Medicine Authorised

● Country: Lebanon
● Form: Tablet
● Package Size: Box of 30
● Public Price: 3247029 LBP ( 3,247,029.00 LBP )
● Pack size unit used: 30
● Cost/Unit: 108234,3 LBP ( 108,234.00 LBP )
● Pricing Date: 10/01/2024

● Country: Portugal
● Package Size: 30
● Reference: Autoridade Nacional do Medicamento e Produtos de Saúde
● Pricing Date: 22/04/2019

● Country: New Zealand
● Package Size: 30 tab
● Exfactory Price: 6512.29 NZD
● Reference: New Zealand Pharmaceutical Management Agency
● Pricing Date: 01/04/2020
● Type: Medicine Authorised

    ◼ Lebanon
    ◼ Country of Origin
    ◼ Reference Countries
    ◼ Other Countries

Note

Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 190,6543 EUR ( 3,492,209.50 LBP )
● Cost/Day: 190,65 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5719,5 EUR ( 105,115,505.95 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 190,6543 EUR ( 3,492,209.50 LBP )
● Cost/Day: 190,65 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5719,5 EUR ( 105,115,505.95 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 190,6543 EUR ( 3,492,209.50 LBP )
● Cost/Day: 190,65 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5719,5 EUR ( 105,115,505.95 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 190,6543 EUR ( 3,492,209.50 LBP )
● Cost/Day: 190,65 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5719,5 EUR ( 105,115,505.95 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 190,6543 EUR ( 3,492,209.50 LBP )
● Cost/Day: 190,65 EUR ( 3,492,209.50 LBP )
● Cost/Month: 5719,5 EUR ( 105,115,505.95 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 725,9333 QAR ( 3,009,156.00 LBP )
● Cost/Day: 725,93 QAR ( 3,009,156.00 LBP )
● Cost/Month: 21777,9 QAR ( 90,386,745.12 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 725,9333 QAR ( 3,009,156.00 LBP )
● Cost/Day: 725,93 QAR ( 3,009,156.00 LBP )
● Cost/Month: 21777,9 QAR ( 90,386,745.12 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 725,9333 QAR ( 3,009,156.00 LBP )
● Cost/Day: 725,93 QAR ( 3,009,156.00 LBP )
● Cost/Month: 21777,9 QAR ( 90,386,745.12 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 725,9333 QAR ( 3,009,156.00 LBP )
● Cost/Day: 725,93 QAR ( 3,009,156.00 LBP )
● Cost/Month: 21777,9 QAR ( 90,386,745.12 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 725,9333 QAR ( 3,009,156.00 LBP )
● Cost/Day: 725,93 QAR ( 3,009,156.00 LBP )
● Cost/Month: 21777,9 QAR ( 90,386,745.12 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 76,432 OMR ( 2,986,838.00 LBP )
● Cost/Day: 76,43 OMR ( 2,986,838.00 LBP )
● Cost/Month: 2292,9 OMR ( 90,076,746.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 76,432 OMR ( 2,986,838.00 LBP )
● Cost/Day: 76,43 OMR ( 2,986,838.00 LBP )
● Cost/Month: 2292,9 OMR ( 90,076,746.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 76,432 OMR ( 2,986,838.00 LBP )
● Cost/Day: 76,43 OMR ( 2,986,838.00 LBP )
● Cost/Month: 2292,9 OMR ( 90,076,746.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 76,432 OMR ( 2,986,838.00 LBP )
● Cost/Day: 76,43 OMR ( 2,986,838.00 LBP )
● Cost/Month: 2292,9 OMR ( 90,076,746.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 76,432 OMR ( 2,986,838.00 LBP )
● Cost/Day: 76,43 OMR ( 2,986,838.00 LBP )
● Cost/Month: 2292,9 OMR ( 90,076,746.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 678,3333 AED ( 2,787,230.88 LBP )
● Cost/Day: 678,33 AED ( 2,787,230.88 LBP )
● Cost/Month: 20349,9 AED ( 83,653,925.04 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 64,5207 BHD ( 2,567,729.28 LBP )
● Cost/Day: 64,52 BHD ( 2,567,729.28 LBP )
● Cost/Month: 1935,6 BHD ( 77,633,689.95 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 64,5207 BHD ( 2,567,729.28 LBP )
● Cost/Day: 64,52 BHD ( 2,567,729.28 LBP )
● Cost/Month: 1935,6 BHD ( 77,633,689.95 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 64,5207 BHD ( 2,567,729.28 LBP )
● Cost/Day: 64,52 BHD ( 2,567,729.28 LBP )
● Cost/Month: 1935,6 BHD ( 77,633,689.95 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 64,5207 BHD ( 2,567,729.28 LBP )
● Cost/Day: 64,52 BHD ( 2,567,729.28 LBP )
● Cost/Month: 1935,6 BHD ( 77,633,689.95 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 64,5207 BHD ( 2,567,729.28 LBP )
● Cost/Day: 64,52 BHD ( 2,567,729.28 LBP )
● Cost/Month: 1935,6 BHD ( 77,633,689.95 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 117,5173 JOD ( 2,496,802.23 LBP )
● Cost/Day: 117,52 JOD ( 2,496,802.23 LBP )
● Cost/Month: 3525,6 JOD ( 75,224,169.75 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 117,5173 JOD ( 2,496,802.23 LBP )
● Cost/Day: 117,52 JOD ( 2,496,802.23 LBP )
● Cost/Month: 3525,6 JOD ( 75,224,169.75 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 117,5173 JOD ( 2,496,802.23 LBP )
● Cost/Day: 117,52 JOD ( 2,496,802.23 LBP )
● Cost/Month: 3525,6 JOD ( 75,224,169.75 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 117,5173 JOD ( 2,496,802.23 LBP )
● Cost/Day: 117,52 JOD ( 2,496,802.23 LBP )
● Cost/Month: 3525,6 JOD ( 75,224,169.75 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 117,5173 JOD ( 2,496,802.23 LBP )
● Cost/Day: 117,52 JOD ( 2,496,802.23 LBP )
● Cost/Month: 3525,6 JOD ( 75,224,169.75 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Day: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Month: 3990,6 EUR ( 73,336,399.50 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Day: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Month: 3990,6 EUR ( 73,336,399.50 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Day: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Month: 3990,6 EUR ( 73,336,399.50 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Day: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Month: 3990,6 EUR ( 73,336,399.50 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Day: 133,02 EUR ( 2,444,546.65 LBP )
● Cost/Month: 3990,6 EUR ( 73,336,399.50 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 129,4583 EUR ( 2,371,026.45 LBP )
● Cost/Day: 129,46 EUR ( 2,371,026.45 LBP )
● Cost/Month: 3883,8 EUR ( 71,369,734.15 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 129,4583 EUR ( 2,371,026.45 LBP )
● Cost/Day: 129,46 EUR ( 2,371,026.45 LBP )
● Cost/Month: 3883,8 EUR ( 71,369,734.15 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 129,4583 EUR ( 2,371,026.45 LBP )
● Cost/Day: 129,46 EUR ( 2,371,026.45 LBP )
● Cost/Month: 3883,8 EUR ( 71,369,734.15 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 129,4583 EUR ( 2,371,026.45 LBP )
● Cost/Day: 129,46 EUR ( 2,371,026.45 LBP )
● Cost/Month: 3883,8 EUR ( 71,369,734.15 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 129,4583 EUR ( 2,371,026.45 LBP )
● Cost/Day: 129,46 EUR ( 2,371,026.45 LBP )
● Cost/Month: 3883,8 EUR ( 71,369,734.15 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 962,3967 DKK ( 2,367,453.14 LBP )
● Cost/Day: 962,4 DKK ( 2,367,453.14 LBP )
● Cost/Month: 28872 DKK ( 71,053,125.84 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 962,3967 DKK ( 2,367,453.14 LBP )
● Cost/Day: 962,4 DKK ( 2,367,453.14 LBP )
● Cost/Month: 28872 DKK ( 71,053,125.84 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 962,3967 DKK ( 2,367,453.14 LBP )
● Cost/Day: 962,4 DKK ( 2,367,453.14 LBP )
● Cost/Month: 28872 DKK ( 71,053,125.84 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 962,3967 DKK ( 2,367,453.14 LBP )
● Cost/Day: 962,4 DKK ( 2,367,453.14 LBP )
● Cost/Month: 28872 DKK ( 71,053,125.84 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 962,3967 DKK ( 2,367,453.14 LBP )
● Cost/Day: 962,4 DKK ( 2,367,453.14 LBP )
● Cost/Month: 28872 DKK ( 71,053,125.84 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 121,9683 EUR ( 2,223,986.05 LBP )
● Cost/Day: 121,97 EUR ( 2,223,986.05 LBP )
● Cost/Month: 3659,1 EUR ( 67,252,602.95 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 121,9683 EUR ( 2,223,986.05 LBP )
● Cost/Day: 121,97 EUR ( 2,223,986.05 LBP )
● Cost/Month: 3659,1 EUR ( 67,252,602.95 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 121,9683 EUR ( 2,223,986.05 LBP )
● Cost/Day: 121,97 EUR ( 2,223,986.05 LBP )
● Cost/Month: 3659,1 EUR ( 67,252,602.95 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 121,9683 EUR ( 2,223,986.05 LBP )
● Cost/Day: 121,97 EUR ( 2,223,986.05 LBP )
● Cost/Month: 3659,1 EUR ( 67,252,602.95 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 121,9683 EUR ( 2,223,986.05 LBP )
● Cost/Day: 121,97 EUR ( 2,223,986.05 LBP )
● Cost/Month: 3659,1 EUR ( 67,252,602.95 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Day: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Month: 580788 ISK ( 64,386,157.68 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Day: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Month: 580788 ISK ( 64,386,157.68 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Day: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Month: 580788 ISK ( 64,386,157.68 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Day: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Month: 580788 ISK ( 64,386,157.68 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Day: 19359,6 ISK ( 2,146,138.74 LBP )
● Cost/Month: 580788 ISK ( 64,386,157.68 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 116,372 EUR ( 2,132,085.80 LBP )
● Cost/Day: 116,37 EUR ( 2,132,085.80 LBP )
● Cost/Month: 3491,1 EUR ( 64,164,754.55 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 116,372 EUR ( 2,132,085.80 LBP )
● Cost/Day: 116,37 EUR ( 2,132,085.80 LBP )
● Cost/Month: 3491,1 EUR ( 64,164,754.55 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 116,372 EUR ( 2,132,085.80 LBP )
● Cost/Day: 116,37 EUR ( 2,132,085.80 LBP )
● Cost/Month: 3491,1 EUR ( 64,164,754.55 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 116,372 EUR ( 2,132,085.80 LBP )
● Cost/Day: 116,37 EUR ( 2,132,085.80 LBP )
● Cost/Month: 3491,1 EUR ( 64,164,754.55 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 116,372 EUR ( 2,132,085.80 LBP )
● Cost/Day: 116,37 EUR ( 2,132,085.80 LBP )
● Cost/Month: 3491,1 EUR ( 64,164,754.55 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 1176,0477 SEK ( 2,116,929.36 LBP )
● Cost/Day: 1176,05 SEK ( 2,116,929.36 LBP )
● Cost/Month: 35281,5 SEK ( 63,509,680.91 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 1176,0477 SEK ( 2,116,929.36 LBP )
● Cost/Day: 1176,05 SEK ( 2,116,929.36 LBP )
● Cost/Month: 35281,5 SEK ( 63,509,680.91 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 1176,0477 SEK ( 2,116,929.36 LBP )
● Cost/Day: 1176,05 SEK ( 2,116,929.36 LBP )
● Cost/Month: 35281,5 SEK ( 63,509,680.91 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 1176,0477 SEK ( 2,116,929.36 LBP )
● Cost/Day: 1176,05 SEK ( 2,116,929.36 LBP )
● Cost/Month: 35281,5 SEK ( 63,509,680.91 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 1176,0477 SEK ( 2,116,929.36 LBP )
● Cost/Day: 1176,05 SEK ( 2,116,929.36 LBP )
● Cost/Month: 35281,5 SEK ( 63,509,680.91 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 1195,0067 NOK ( 2,067,672.65 LBP )
● Cost/Day: 1195,01 NOK ( 2,067,672.65 LBP )
● Cost/Month: 35850,3 NOK ( 62,030,179.50 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 1195,0067 NOK ( 2,067,672.65 LBP )
● Cost/Day: 1195,01 NOK ( 2,067,672.65 LBP )
● Cost/Month: 35850,3 NOK ( 62,030,179.50 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 1195,0067 NOK ( 2,067,672.65 LBP )
● Cost/Day: 1195,01 NOK ( 2,067,672.65 LBP )
● Cost/Month: 35850,3 NOK ( 62,030,179.50 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 1195,0067 NOK ( 2,067,672.65 LBP )
● Cost/Day: 1195,01 NOK ( 2,067,672.65 LBP )
● Cost/Month: 35850,3 NOK ( 62,030,179.50 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 1195,0067 NOK ( 2,067,672.65 LBP )
● Cost/Day: 1195,01 NOK ( 2,067,672.65 LBP )
● Cost/Month: 35850,3 NOK ( 62,030,179.50 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 108,8587 EUR ( 1,985,045.40 LBP )
● Cost/Day: 108,86 EUR ( 1,985,045.40 LBP )
● Cost/Month: 3265,8 EUR ( 60,010,863.25 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 108,8587 EUR ( 1,985,045.40 LBP )
● Cost/Day: 108,86 EUR ( 1,985,045.40 LBP )
● Cost/Month: 3265,8 EUR ( 60,010,863.25 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 108,8587 EUR ( 1,985,045.40 LBP )
● Cost/Day: 108,86 EUR ( 1,985,045.40 LBP )
● Cost/Month: 3265,8 EUR ( 60,010,863.25 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 108,8587 EUR ( 1,985,045.40 LBP )
● Cost/Day: 108,86 EUR ( 1,985,045.40 LBP )
● Cost/Month: 3265,8 EUR ( 60,010,863.25 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 108,8587 EUR ( 1,985,045.40 LBP )
● Cost/Day: 108,86 EUR ( 1,985,045.40 LBP )
● Cost/Month: 3265,8 EUR ( 60,010,863.25 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 102,115 EUR ( 1,874,765.10 LBP )
● Cost/Day: 102,12 EUR ( 1,874,765.10 LBP )
● Cost/Month: 3063,6 EUR ( 56,298,093.15 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 102,115 EUR ( 1,874,765.10 LBP )
● Cost/Day: 102,12 EUR ( 1,874,765.10 LBP )
● Cost/Month: 3063,6 EUR ( 56,298,093.15 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 102,115 EUR ( 1,874,765.10 LBP )
● Cost/Day: 102,12 EUR ( 1,874,765.10 LBP )
● Cost/Month: 3063,6 EUR ( 56,298,093.15 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 102,115 EUR ( 1,874,765.10 LBP )
● Cost/Day: 102,12 EUR ( 1,874,765.10 LBP )
● Cost/Month: 3063,6 EUR ( 56,298,093.15 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 102,115 EUR ( 1,874,765.10 LBP )
● Cost/Day: 102,12 EUR ( 1,874,765.10 LBP )
● Cost/Month: 3063,6 EUR ( 56,298,093.15 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Day: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Month: 2673 GBP ( 53,863,008.21 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Day: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Month: 2673 GBP ( 53,863,008.21 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Day: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Month: 2673 GBP ( 53,863,008.21 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Day: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Month: 2673 GBP ( 53,863,008.21 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Day: 89,1 GBP ( 1,793,418.53 LBP )
● Cost/Month: 2673 GBP ( 53,863,008.21 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 2385,0153 CZK ( 1,647,462.60 LBP )
● Cost/Day: 2385,02 CZK ( 1,647,462.60 LBP )
● Cost/Month: 71550,6 CZK ( 49,423,878.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 2385,0153 CZK ( 1,647,462.60 LBP )
● Cost/Day: 2385,02 CZK ( 1,647,462.60 LBP )
● Cost/Month: 71550,6 CZK ( 49,423,878.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 2385,0153 CZK ( 1,647,462.60 LBP )
● Cost/Day: 2385,02 CZK ( 1,647,462.60 LBP )
● Cost/Month: 71550,6 CZK ( 49,423,878.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 2385,0153 CZK ( 1,647,462.60 LBP )
● Cost/Day: 2385,02 CZK ( 1,647,462.60 LBP )
● Cost/Month: 71550,6 CZK ( 49,423,878.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 2385,0153 CZK ( 1,647,462.60 LBP )
● Cost/Day: 2385,02 CZK ( 1,647,462.60 LBP )
● Cost/Month: 71550,6 CZK ( 49,423,878.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 89,7593 EUR ( 1,635,824.45 LBP )
● Cost/Day: 89,76 EUR ( 1,635,824.45 LBP )
● Cost/Month: 2692,8 EUR ( 49,479,094.60 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 89,7593 EUR ( 1,635,824.45 LBP )
● Cost/Day: 89,76 EUR ( 1,635,824.45 LBP )
● Cost/Month: 2692,8 EUR ( 49,479,094.60 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 89,7593 EUR ( 1,635,824.45 LBP )
● Cost/Day: 89,76 EUR ( 1,635,824.45 LBP )
● Cost/Month: 2692,8 EUR ( 49,479,094.60 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 89,7593 EUR ( 1,635,824.45 LBP )
● Cost/Day: 89,76 EUR ( 1,635,824.45 LBP )
● Cost/Month: 2692,8 EUR ( 49,479,094.60 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 89,7593 EUR ( 1,635,824.45 LBP )
● Cost/Day: 89,76 EUR ( 1,635,824.45 LBP )
● Cost/Month: 2692,8 EUR ( 49,479,094.60 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 80,1363 EUR ( 1,470,404.00 LBP )
● Cost/Day: 80,14 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2404,2 EUR ( 44,185,640.20 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 80,1363 EUR ( 1,470,404.00 LBP )
● Cost/Day: 80,14 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2404,2 EUR ( 44,185,640.20 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 80,1363 EUR ( 1,470,404.00 LBP )
● Cost/Day: 80,14 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2404,2 EUR ( 44,185,640.20 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 80,1363 EUR ( 1,470,404.00 LBP )
● Cost/Day: 80,14 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2404,2 EUR ( 44,185,640.20 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 80,1363 EUR ( 1,470,404.00 LBP )
● Cost/Day: 80,14 EUR ( 1,470,404.00 LBP )
● Cost/Month: 2404,2 EUR ( 44,185,640.20 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 83,3083 CHF ( 1,416,000.75 LBP )
● Cost/Day: 83,31 CHF ( 1,416,000.75 LBP )
● Cost/Month: 2499,3 CHF ( 42,633,564.75 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 83,3083 CHF ( 1,416,000.75 LBP )
● Cost/Day: 83,31 CHF ( 1,416,000.75 LBP )
● Cost/Month: 2499,3 CHF ( 42,633,564.75 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 83,3083 CHF ( 1,416,000.75 LBP )
● Cost/Day: 83,31 CHF ( 1,416,000.75 LBP )
● Cost/Month: 2499,3 CHF ( 42,633,564.75 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 83,3083 CHF ( 1,416,000.75 LBP )
● Cost/Day: 83,31 CHF ( 1,416,000.75 LBP )
● Cost/Month: 2499,3 CHF ( 42,633,564.75 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 83,3083 CHF ( 1,416,000.75 LBP )
● Cost/Day: 83,31 CHF ( 1,416,000.75 LBP )
● Cost/Month: 2499,3 CHF ( 42,633,564.75 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Day: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Month: 2256 EUR ( 41,465,392.80 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Day: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Month: 2256 EUR ( 41,465,392.80 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Day: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Month: 2256 EUR ( 41,465,392.80 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Day: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Month: 2256 EUR ( 41,465,392.80 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Day: 75,2 EUR ( 1,378,503.75 LBP )
● Cost/Month: 2256 EUR ( 41,465,392.80 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 331,363 TRY ( 635,748.39 LBP )
● Cost/Day: 331,36 TRY ( 635,748.39 LBP )
● Cost/Month: 9940,8 TRY ( 19,091,658.60 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 331,363 TRY ( 635,748.39 LBP )
● Cost/Day: 331,36 TRY ( 635,748.39 LBP )
● Cost/Month: 9940,8 TRY ( 19,091,658.60 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 331,363 TRY ( 635,748.39 LBP )
● Cost/Day: 331,36 TRY ( 635,748.39 LBP )
● Cost/Month: 9940,8 TRY ( 19,091,658.60 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 331,363 TRY ( 635,748.39 LBP )
● Cost/Day: 331,36 TRY ( 635,748.39 LBP )
● Cost/Month: 9940,8 TRY ( 19,091,658.60 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 331,363 TRY ( 635,748.39 LBP )
● Cost/Day: 331,36 TRY ( 635,748.39 LBP )
● Cost/Month: 9940,8 TRY ( 19,091,658.60 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 636,6667 EGP ( 610,623.60 LBP )
● Cost/Day: 636,67 EGP ( 610,623.60 LBP )
● Cost/Month: 19100,1 EGP ( 18,337,910.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 636,6667 EGP ( 610,623.60 LBP )
● Cost/Day: 636,67 EGP ( 610,623.60 LBP )
● Cost/Month: 19100,1 EGP ( 18,337,910.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 636,6667 EGP ( 610,623.60 LBP )
● Cost/Day: 636,67 EGP ( 610,623.60 LBP )
● Cost/Month: 19100,1 EGP ( 18,337,910.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 636,6667 EGP ( 610,623.60 LBP )
● Cost/Day: 636,67 EGP ( 610,623.60 LBP )
● Cost/Month: 19100,1 EGP ( 18,337,910.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 636,6667 EGP ( 610,623.60 LBP )
● Cost/Day: 636,67 EGP ( 610,623.60 LBP )
● Cost/Month: 19100,1 EGP ( 18,337,910.00 LBP )
Breast cancer postmenopausal, hormone receptor-positive : (Adults)
● Cost/Unit: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Day: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Month: 3247029 LBP ( 3,247,029.00 LBP )
Gastro-intestinal neuroendocrine tumours : (Adults)
● Cost/Unit: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Day: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Month: 3247029 LBP ( 3,247,029.00 LBP )
Pancreatic neuroendocrine tumours : (Adults)
● Cost/Unit: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Day: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Month: 3247029 LBP ( 3,247,029.00 LBP )
Pulmonary neuroendocrine tumours : (Adults)
● Cost/Unit: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Day: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Month: 3247029 LBP ( 3,247,029.00 LBP )
Renal cell carcinoma : (Adults)
● Cost/Unit: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Day: 108234,3 LBP ( 108,234.00 LBP )
● Cost/Month: 3247029 LBP ( 3,247,029.00 LBP )
Prices are provided in Dollar ($)
You have to register to view this info

You have to register to view this info

You have to register to view this info